Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of BridgeBio Pharma Inc (NASDAQ: BBIO) closed at $38.40 in the last session, up 0.10% from day before closing price of $38.36. In other words, the price has increased by $0.10 from its previous closing price. On the day, 4.72 million shares were traded. BBIO stock price reached its highest trading level at $38.615 during the session, while it also had its lowest trading level at $36.85.
Ratios:
We take a closer look at BBIO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.54 and its Current Ratio is at 4.57.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on March 31, 2025, initiated with a Buy rating and assigned the stock a target price of $50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 22 ’25 when Kumar Neil sold 75,000 shares for $34.11 per share. The transaction valued at 2,558,025 led to the insider holds 4,873,447 shares of the business.
Ellis Andrea sold 10,000 shares of BBIO for $350,000 on Apr 14 ’25. The Director now owns 12,000 shares after completing the transaction at $35.00 per share. On Apr 14 ’25, another insider, ANDREA ELLIS, who serves as the Director of the company, bought 10,000 shares for $35.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BBIO now has a Market Capitalization of 7291430400 and an Enterprise Value of 8618799104. For the stock, the TTM Price-to-Sale (P/S) ratio is 57.22. Its current Enterprise Value per Revenue stands at 67.644 whereas that against EBITDA is -13.007.
Stock Price History:
The Beta on a monthly basis for BBIO is 1.15, which has changed by 0.37980592 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, BBIO has reached a high of $39.54, while it has fallen to a 52-week low of $21.62. The 50-Day Moving Average of the stock is 12.18%, while the 200-Day Moving Average is calculated to be 31.28%.
Shares Statistics:
According to the various share statistics, BBIO traded on average about 3.12M shares per day over the past 3-months and 3406880 shares per day over the past 10 days. A total of 189.83M shares are outstanding, with a floating share count of 155.23M. Insiders hold about 18.24% of the company’s shares, while institutions hold 76.84% stake in the company. Shares short for BBIO as of 1744675200 were 22312587 with a Short Ratio of 7.15, compared to 1741910400 on 21759460. Therefore, it implies a Short% of Shares Outstanding of 22312587 and a Short% of Float of 17.950001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
